Applied DNA Biotherapeutics Subsidiary Reports LinearDNA™ Platform Development Milestone: First Successful Administration of LinearDNA In Vivo via Lipid Nanoparticles (LNP)

– Use of LNP Simplifies Administration of LinearDNA-based Therapies, Potentially Enabling Their Application in Large Scale – STONY BROOK, N.Y.–(BUSINESS WIRE)–$APDN #LNP—Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in PCR-based DNA technologies, today announced that LineaRx, the Company’s majority-owned biotherapeutics subsidiary, has for the first time successfully administered and expressed a linearDNA-LNP … [Read more…]

Adtalem Global Education Medical Schools Partner with Southern California University to Expand Pipeline of Physicians

Partnership enhances educational pathways to medicine and provides up to $10,000 in additional student funding CHICAGO–(BUSINESS WIRE)–$ATGE #WeAreAdtalem–Adtalem Global Education (NYSE: ATGE), a leading educator and provider of professional talent to the healthcare industry, has established a partnership between its two medical schools, American University of the Caribbean School of Medicine (AUC) and Ross University … [Read more…]

PrimeRevenue Releases eBook on Supply Chain Financing for Healthcare Industry

ATLANTA–(BUSINESS WIRE)–PrimeRevenue, the global leader in working capital and B2B payment solutions, today published its new eBook, How Supply Chain Financing Brings the Healthcare Supply Chain to Scale. Written for pharmaceutical and medical product manufacturers, the guide provides an analysis of the challenges currently facing healthcare suppliers—and outlines the ways in which supply chain finance … [Read more…]

Rockley Establishes Scientific Advisory Board of Prominent Scientists and Medical Experts

– Assembly of recognized experts to bring complementary experience and insights to Rockley’s ongoing efforts to revolutionize wearable biosensing technology OXFORD, England & PASADENA, Calif.–(BUSINESS WIRE)–Rockley Photonics Holdings Limited (NYSE: RKLY) (“Rockley”), a global leader in photonics-based health monitoring and communications solutions, today announced the formation of a scientific advisory board (SAB) gathering world-renowned experts … [Read more…]

UnitedHealthcare Donates $1 Million to Nonprofits in Michigan

Funding is part of UnitedHealthcare’s $11 million in Empowering Health grants focused on expanding access to care and addressing the social determinants of health for people in underserved communities DETROIT–(BUSINESS WIRE)–UnitedHealthcare, a UnitedHealth Group (NYSE: UNH) company, is awarding $1 million in Empowering Health grants to five community-based organizations in Michigan to expand access to … [Read more…]

UnitedHealthcare Donates $500,000 to Nonprofits in Oklahoma

Funding is part of UnitedHealthcare’s $11 million in Empowering Health grants focused on expanding access to care and addressing the social determinants of health for people in underserved communities OKLAHOMA CITY–(BUSINESS WIRE)–UnitedHealthcare, a UnitedHealth Group (NYSE: UNH) company, is awarding $500,000 in Empowering Health grants to three community-based organizations in Oklahoma to expand access to … [Read more…]

Tivic Health to Report Second Quarter 2022 Earnings on August 15 Via Conference Call and Webcast

SAN FRANCISCO–(BUSINESS WIRE)–$TIVC #healthcare—Tivic Health® Systems, Inc. (Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced that it will report financial results for the second quarter of 2022 via conference call and webcast, Monday, August 15, 2022, at 1:30 pm PT / 4:30 pm ET. Teleconference Details: Toll-Free: 877-545-0320 … [Read more…]

Aro Biotherapeutics Receives FDA Orphan Drug Designation for ABX1100 for the Treatment of Pompe Disease

PHILADELPHIA–(BUSINESS WIRE)–Aro Biotherapeutics, a biotechnology company pioneering the development of tissue-targeted genetic medicines, today announced that the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation for ABX1100, an investigational Centyrin-siRNA conjugate that targets the Gys1 gene in the muscle, for the treatment of Pompe disease. “We are pleased to have received this designation … [Read more…]

Manatt Expands Data Strategy and Health IT Capabilities in Boston

BOSTON–(BUSINESS WIRE)–Manatt, Phelps & Phillips, LLP, a multidisciplinary, integrated professional services firm, announced today that Cynthia Bero has joined its Boston office as a Manatt Health senior advisor. Bero joins Manatt from Mass General Brigham (MGB), where she spent over 20 years in senior information technology positions, most recently as Vice President of Information Systems. … [Read more…]

Prellis Biologics Appoints New CEO, Raises $35 Million in Series C Funding to Leverage Human Immune System Biology to De-Risk and Accelerate Therapeutics Drug Discovery and Development

Former Generate Biomedicines, Amgen and Novartis senior leader Mike Nohaile joins Prellis as CEO SAN FRANCISCO–(BUSINESS WIRE)–Prellis Biologics, Inc (Prellis Bio), a biotherapeutics company, today appointed Michael Nohaile, PhD as its new CEO and announced it has raised a $35 million Series C funding round, co-led by Celesta Capital and Avidity Partners with participation from … [Read more…]